Search research articles
Contact Us
Filters
Showing results (61-70 of 90) with videos related to
Page
of 9
Sort By:
MMW Fortschritte Der Medizin
|
March 20, 2020
[Neurostimulation by music - an overview]
Wesley Dean Jones, Aref Kalantari, Andreas Otte
European Journal of Nuclear Medicine and Molecular Imaging
|
January 23, 2003
90Y-DOTATOC and nephrotoxicity
Andreas Otte, Markus Cybulla, Stefan M Weiner
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
April 16, 2002
Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?
Markus Cybulla, Stefan M Weiner, Andreas Otte
Lancet (London, England)
|
March 29, 2002
Is radiation nephropathy caused by yttrium-90?
Andreas Otte, Stefan M Weiner, Markus Cybulla
Nuclear Medicine Communications
|
June 9, 2005
Good clinical practice: historical background and key aspects
Andreas Otte, Herbert Maier-Lenz, Rudi A Dierckx
Archiv Fur Kriminologie
|
November 10, 2015
[Use of sonography in splinter injuries: a model simulation]
Xhovalin Dizdari, Gennadie Keister, Johannes Zimmer, et al.
Ebiomedicine
|
October 10, 2019
Neuroprosthetics 2.0
Simon Hazubski, Surjo R Soekadar, Harald Hoppe, et al.
Nuclear Medicine Communications
|
November 21, 2008
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step
Andreas Otte, Christophe van de Wiele, Rudi A Dierckx
Nuclear Medicine Communications
|
August 13, 2005
Functional neuroimaging endpoints in drug development
Andreas Otte, Kurt Audenaert, Kathelijne Peremans, et al.
Sleep
|
April 10, 2003
Brain SPECT in sleep research
Andreas Otte, Kurt Audenaert, Eric A Nofzinger, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 90) with videos related to
Sort By:
Page
of 9
MMW Fortschritte Der Medizin
|
March 20, 2020
[Neurostimulation by music - an overview]
Wesley Dean Jones, Aref Kalantari, Andreas Otte
European Journal of Nuclear Medicine and Molecular Imaging
|
January 23, 2003
90Y-DOTATOC and nephrotoxicity
Andreas Otte, Markus Cybulla, Stefan M Weiner
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
April 16, 2002
Is (90)Y-DOTATOC treatment for neuroendocrine tumours safe?
Markus Cybulla, Stefan M Weiner, Andreas Otte
Lancet (London, England)
|
March 29, 2002
Is radiation nephropathy caused by yttrium-90?
Andreas Otte, Stefan M Weiner, Markus Cybulla
Nuclear Medicine Communications
|
June 9, 2005
Good clinical practice: historical background and key aspects
Andreas Otte, Herbert Maier-Lenz, Rudi A Dierckx
Archiv Fur Kriminologie
|
November 10, 2015
[Use of sonography in splinter injuries: a model simulation]
Xhovalin Dizdari, Gennadie Keister, Johannes Zimmer, et al.
Ebiomedicine
|
October 10, 2019
Neuroprosthetics 2.0
Simon Hazubski, Surjo R Soekadar, Harald Hoppe, et al.
Nuclear Medicine Communications
|
November 21, 2008
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step
Andreas Otte, Christophe van de Wiele, Rudi A Dierckx
Nuclear Medicine Communications
|
August 13, 2005
Functional neuroimaging endpoints in drug development
Andreas Otte, Kurt Audenaert, Kathelijne Peremans, et al.
Sleep
|
April 10, 2003
Brain SPECT in sleep research
Andreas Otte, Kurt Audenaert, Eric A Nofzinger, et al.
Page
of 9